6.3 Diabetes Mellitus and Endocrine Emergencies

6.3 Diabetes Mellitus and Endocrine Emergencies

Endocrine homeostasis is maintained through intricate hormonal feedback mechanisms regulating cellular metabolism, fluid-electrolyte balance, and cardiovascular tone. Acute decompensation of the endocrine system results in life-threatening metabolic crises—including severe hypoglycemia, Diabetic Ketoacidosis (DKA), Hyperosmolar Hyperglycemic State (HHS), Thyroid Storm, Myxedema Coma, and Addisonian Crisis. Nursing professionals must master the pathophysiology, pharmacokinetic principles, and critical resuscitation protocols required to manage these emergencies.

---

Diabetes Mellitus: Etiology & Diagnostic Benchmarks

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia resulting from defects in insulin secretion, insulin action, or both.

Type 1 vs. Type 2 Diabetes Mellitus

ADA Diagnostic Benchmarks

According to the American Diabetes Association (ADA) Standards of Care, diabetes is diagnosed by any of the following criteria (criteria 1 to 3 require confirmation by repeat testing on a subsequent day in the absence of unequivocal symptomatic hyperglycemia):

1. Fasting Plasma Glucose (FPG) >= 126 mg/dL (7.0 mmol/L) after an overnight caloric fast of at least 8 hours.
2. 2-Hour Plasma Glucose >= 200 mg/dL (11.1 mmol/L) during a standard 75-gram Oral Glucose Tolerance Test (OGTT).
3. Glycated Hemoglobin (HbA1c) >= 6.5% (48 mmol/mol), reflecting average glycemia over the preceding 2 to 3 months (erythrocyte lifespan).
4. Random (Casual) Plasma Glucose >= 200 mg/dL (11.1 mmol/L) in a patient exhibiting classic symptoms of hyperglycemia (polyuria, polydipsia, polyphagia, unexplained weight loss) or acute hyperglycemic crisis.

---

Insulin Pharmacology, Administration & Site Rotation

Exogenous insulin replaces physiological basal and prandial insulin secretion. Understanding the distinct pharmacokinetics of each insulin analog is vital for safe medication administration.

Pharmacokinetics of Insulin Formulations

The "Clear Before Cloudy" Mixing Sequence

When combining Regular insulin (clear, short-acting) and NPH insulin (cloudy, intermediate-acting) in a single syringe, the nurse must strictly adhere to the standardized sequence:

Step 1: Inject air into NPH vial (cloudy) ---> Step 2: Inject air into Regular vial (clear)
Step 3: Draw prescribed Regular insulin (clear) ---> Step 4: Draw prescribed NPH insulin (cloudy)

• Clinical Rationale: Drawing "Clear before Cloudy" (Regular before NPH) prevents accidental contamination of the pure, short-acting Regular insulin vial with the protamine modifying proteins present in the NPH vial. Contaminating the Regular vial with protamine would inadvertently slow its onset, rendering it ineffective for rapid prandial coverage.

Injection Technique & Prevention of Lipohypertrophy

• Subcutaneous insulin is injected at a 90-degree angle into healthy subcutaneous tissue (or a 45-degree angle in cachectic patients or young children with minimal adipose depth).
• Absorption rates vary systematically across anatomical regions: Abdomen (fastest, most uniform absorption) > Outer posterior arms > Anterior thighs > Buttocks/hips.
• Systematic Site Rotation: Patients must rotate injection sites systematically within one anatomical region (e.g., rotating 1 inch apart across abdominal quadrants for 1 to 2 weeks before switching to the thighs). Repeated injections into the same focal site trigger lipohypertrophy (fibrous fat mass accumulation), which drastically delays and disrupts insulin absorption, leading to erratic glycemic swings.

---

Hypoglycemia Assessment & The Rule of 15

Hypoglycemia is defined as a blood glucose level < 70 mg/dL (3.9 mmol/L). Severe, clinically significant hypoglycemia occurs at < 54 mg/dL (3.0 mmol/L).

Clinical Manifestations

• Autonomic / Sympathetic Signs: Mediated by compensatory epinephrine and norepinephrine surges: diaphoresis, fine tremors, tachycardia, palpitations, severe anxiety, hunger, and pallor. Note: Patients taking non-selective beta-blockers (e.g., Propranolol) will have sympathetic symptoms masked, except for diaphoresis!
• Neuroglycopenic Signs: Direct central nervous system glucose starvation: headache, impaired concentration, confusion, irritability, slurred speech, ataxia, blurred vision, seizures, and coma.

The "Rule of 15" for Conscious Patients

For an alert patient who is conscious and able to swallow safely:

1. Administer 15 grams of fast-acting simple carbohydrate: Examples include 120 mL (4 oz) of fruit juice or non-diet soda, 3 to 4 glucose tablets, or 1 tablespoon of granulated sugar or honey. Avoid high-fat carbohydrates (chocolate, milk, pastries) because fat delays gastric emptying and significantly slows glucose absorption.
2. Wait 15 minutes while the patient remains resting, then recheck blood glucose via fingerstick.
3. Repeat: If the blood glucose remains < 70 mg/dL, administer another 15 grams of simple carbohydrate and recheck in 15 minutes.
4. Sustain: Once the blood glucose normalizes (>= 70 mg/dL), provide a snack containing complex carbohydrates and protein (e.g., whole wheat crackers with cheese or peanut butter) or serve the patient's scheduled meal within 30 to 60 minutes to prevent rebound hypoglycemia.

Emergency Management in Unconscious or NPO Patients

• Intravenous Access Available: Administer 25 to 50 mL of Dextrose 50% in Water (D50W) via slow IV push through a patent large-bore venous catheter over 2 to 3 minutes. Recheck blood glucose within 10 to 15 minutes. D50W is extremely hypertonic; closely inspect the IV site for extravasation, which causes severe chemical phlebitis and tissue necrosis.
• No Intravenous Access: Administer Glucagon 1 mg intramuscularly (IM) or subcutaneously (or Glucagon 3 mg intranasally). Glucagon stimulates hepatic glycogenolysis, restoring glucose within 10 to 15 minutes.
• CRITICAL POST-GLUCAGON NURSING ACTION: Immediately turn the patient onto their side (lateral recovery position). Glucagon frequently induces sudden, severe nausea and vomiting as consciousness returns; lateral positioning prevents fatal pulmonary aspiration of gastric contents.

---

Diabetic Ketoacidosis (DKA) vs. Hyperosmolar Hyperglycemic State (HHS)

Both DKA and HHS represent life-threatening acute metabolic crises requiring urgent intensive resuscitation:

Comparative Diagnostic Profiles

Integrated Resuscitation Protocol: Fluids, Insulin & Potassium

RESUSCITATION PRIORITIES IN DKA / HHS
  [1. IV Fluid Resuscitation] ---> 0.9% Normal Saline 1000 mL/hr for initial 1-2 hours
  [2. Potassium Check First]  ---> If K+ < 3.3 mEq/L: WITHHOLD INSULIN, replace K+ until ≥ 3.3 mEq/L
  [3. Regular Insulin Infusion] -> 0.1 units/kg/hr IV; target glycemic drop 50 to 75 mg/dL/hr
  [4. Dextrose Addition]     ---> Add 5% Dextrose when glucose reaches 200 mg/dL (DKA) or 250-300 mg/dL (HHS)

1. Fluid Resuscitation (First Priority):
   • Initiate immediate rapid infusion of isotonic 0.9% Normal Saline (0.9% NaCl) at 1,000 mL/hr (15 to 20 mL/kg/hr) during the first 1 to 2 hours to expand circulating intravascular volume, restore blood pressure, and re-establish renal perfusion.
   • Subsequent fluids: Calculate corrected sodium [Measured Na + 0.016 x (Glucose - 100)]. If corrected sodium is normal or elevated, transition to hypotonic 0.45% NaCl at 250 to 500 mL/hr; if corrected sodium is low, continue 0.9% NaCl.
2. The Absolute Potassium Prerequisite:
   • CRITICAL SAFETY RULE: Serum potassium MUST be verified before starting insulin!
   • Insulin promotes rapid cellular uptake of potassium via the sodium-potassium ATPase pump. Administering insulin to a patient with hypokalemia triggers lethal cardiac dysrhythmias (ventricular fibrillation, asystole) and respiratory muscle arrest.
   • If Serum K+ < 3.3 mEq/L: WITHHOLD INSULIN. Administer IV Potassium Chloride (KCl) at 20 to 40 mEq/hr until serum potassium reaches >= 3.3 mEq/L.
   • If Serum K+ is 3.3 to 5.2 mEq/L: Initiate insulin infusion and add 20 to 30 mEq KCl per liter of IV replacement fluids to maintain potassium between 4.0 and 5.0 mEq/L.
   • If Serum K+ > 5.2 mEq/L: Do not add potassium to fluids; initiate insulin and recheck potassium every 2 hours.
3. Intravenous Regular Insulin Infusion:
   • Administer continuous IV Regular insulin at 0.1 units/kg/hr (or an initial IV bolus of 0.1 units/kg followed by 0.1 units/kg/hr). Titrate to achieve a steady, controlled reduction in plasma glucose of 50 to 75 mg/dL per hour.
4. The 5% Dextrose Addition Rule:
   • When blood glucose declines to 200 mg/dL in DKA (or 250 to 300 mg/dL in HHS), add 5% Dextrose to the IV fluids (e.g., 5% Dextrose in 0.45% NaCl) while continuing the insulin infusion.
   • Clinical Rationale: In DKA, continuing insulin is mandatory to suppress lipolysis, clear circulating ketoacids, and normalize the anion gap. However, plasma glucose falls much faster than ketoacids clear. Adding dextrose maintains euglycemia while avoiding rapid plasma osmolality declines that cause free water to rush intracellularly into brain cells, triggering fatal cerebral edema (heralded by sudden headache, lethargy, bradycardia, and pupillary dilation).

---

Life-Threatening Thyroid Emergencies

Thyroid Storm (Thyrotoxic Crisis)

Thyroid storm is an extreme, life-threatening hypermetabolic state triggered by sudden surges of free thyroid hormones (FT3, FT4) or heightened adrenergic receptor responsiveness. Precipitants include systemic infection, major trauma, non-thyroid surgery, radioiodine therapy, or abrupt withdrawal of antithyroid medications in patients with pre-existing hyperthyroidism (Graves' disease).

• Clinical Presentation: Extreme hyperpyrexia (fever > 39.0°C to 41.0°C / 102°F to 106°F), profound sinus tachycardia out of proportion to fever (heart rate > 140 bpm), atrial fibrillation, congestive heart failure, severe agitation, delirium, psychosis, seizures, coma, profuse diaphoresis, severe dehydration, abdominal pain, diarrhea, and jaundice.
• Multimodal Emergency Pharmacotherapy:
  1. Beta-Adrenergic Blockade: Propranolol (IV or oral) administered immediately to block beta-1 and beta-2 receptors, controlling tachycardia, dysrhythmias, diaphoresis, and tremors. Propranolol also uniquely inhibits peripheral conversion of T4 to active T3.
  2. Thionamide Antithyroid Agents: Propylthiouracil (PTU) 200 mg every 4 hours (or Methimazole). PTU is preferred in thyroid storm because it blocks both new thyroid hormone synthesis and peripheral T4 to T3 conversion.
  3. Inorganic Iodine Solutions: Saturated Solution of Potassium Iodide (SSKI) or Lugol's solution. MANDATORY TIMING RULE: Iodine must be administered AT LEAST 1 HOUR AFTER the thionamide (PTU). Administering iodine prior to the thionamide allows the thyroid gland to utilize the iodine as substrate to synthesize and release massive new stores of thyroid hormone, dramatically worsening thyrotoxicosis.
  4. Corticosteroids: Intravenous Hydrocortisone (100 mg IV every 8 hours) to treat relative adrenal insufficiency resulting from hypermetabolism and inhibit peripheral T4 to T3 conversion.
  5. Hyperthermia Control: Apply cooling blankets and administer acetaminophen. CRITICAL CONTRAINDICATION: AVOID ASPIRIN (salicylates) at all costs! Salicylates displace thyroid hormones from Thyroid-Binding Globulin (TBG) and albumin, markedly increasing free circulating T3/T4 concentrations and exacerbating the crisis.

Myxedema Coma

Myxedema coma is the decompensated extreme of severe hypothyroidism, characterized by global metabolic collapse, hypothermia, and central nervous system depression. Triggered in hypothyroid patients by severe infection, exposure to cold, trauma, stroke, sedatives, or abrupt cessation of levothyroxine.

• Clinical Presentation: Profound hypothermia (core temperature < 35.0°C / 95°F), severe hypoventilation with hypercapnic respiratory acidosis, profound bradycardia, hypotension, periorbital and facial non-pitting edema (myxedema facies), macroglossia, dry doughy skin, extreme lethargy progressing to stupor and coma, hyponatremia, and hypoglycemia.
• Emergency Resuscitation:
  1. Intravenous Thyroid Hormone: Administer an immediate IV loading dose of Levothyroxine (T4) 200 to 400 mcg IV, followed by daily IV maintenance doses, with or without IV Liothyronine (T3).
  2. Intravenous Corticosteroid Administration: Intravenous Hydrocortisone 100 mg IV MUST BE ADMINISTERED PRIOR TO OR CONCURRENTLY WITH thyroid hormone. Administering thyroid hormone abruptly accelerates cellular metabolic rates and hepatic clearance of cortisol; if the patient has co-existing secondary adrenal insufficiency or blunted adrenal reserve, thyroid replacement without prior corticosteroid administration will precipitate a fatal Addisonian crisis.
  3. Passive External Rewarming: Apply warm blankets in a warm room. Avoid active external rewarming (e.g., heating blankets, warm baths), which causes sudden cutaneous vasodilation, precipitating profound vascular collapse, refractory shock, and death.
  4. Supportive Care: Mechanical ventilation for respiratory depression; cautious fluid resuscitation; 3% hypertonic saline only for severe hyponatremic seizures.

---

Adrenal Crises: Addisonian Crisis vs. Cushing's Syndrome

Addisonian Crisis (Acute Adrenal Insufficiency)

Addisonian crisis is a life-threatening endocrine emergency resulting from acute, severe deficiency of glucocorticoids (cortisol) and mineralocorticoids (aldosterone).

• Pathophysiology & Presentation:
  • Aldosterone deficiency leads to severe renal sodium and water wasting with potassium retention: produces profound hyponatremia, severe hyperkalemia, hypovolemia, and dehydration.
  • Cortisol deficiency causes impaired hepatic gluconeogenesis and loss of vascular tone responsiveness to circulating catecholamines: produces severe hypoglycemia and refractory hypotension / vascular shock unresponsive to fluid boluses and vasopressors.
  • Precipitating Causes: Major physiological stress (sepsis, surgery, trauma) in patients with primary adrenal insufficiency (Addison's disease) or abrupt cessation of long-term exogenous corticosteroid therapy (which suppresses the hypothalamic-pituitary-adrenal axis).
• Emergency Nursing & Pharmacological Protocols:
  1. Immediate Glucocorticoid Replacement: Administer Intravenous Hydrocortisone 100 mg IV bolus immediately, followed by 100 mg every 6 to 8 hours. Hydrocortisone possesses both potent glucocorticoid activity and mineralocorticoid salt-retaining effects at high doses.
  2. Aggressive Isotonic & Dextrose Resuscitation: Infuse 0.9% Normal Saline combined with 5% Dextrose (0.9% NS + D5W) rapidly to restore circulating blood volume, correct hyponatremia, and reverse life-threatening hypoglycemia.
  3. Cardiac Monitoring: Place patient on continuous cardiac telemetry to detect hyperkalemic dysrhythmias (peaked T waves, widened QRS). Administer IV calcium gluconate if toxic ECG changes emerge.
  4. Patient Education on "Sick Day Rules":
     • Patients on chronic replacement therapy must never discontinue steroids abruptly.
     • Instruct patients to double or triple their oral maintenance dose during acute febrile illness, physical trauma, or minor procedures ("rule of twos and threes").
     • Provide prescriptions and hands-on training for an emergency prefilled syringe of Hydrocortisone 100 mg IM for use during severe vomiting or altered sensorium, and mandate wearing a Medical Alert identification bracelet.

Cushing's Syndrome (Hypercortisolism)

Cushing's syndrome results from prolonged, chronic exposure to excessive glucocorticoid concentrations, either from exogenous corticosteroid administration (iatrogenic) or endogenous hypersecretion (pituitary ACTH-secreting adenoma [Cushing's disease], adrenal cortical neoplasms, or ectopic ACTH from small cell lung carcinoma).

• Clinical Manifestations: Central/truncal obesity, thin extremities with proximal muscle wasting, rounded "moon facies", dorsocervical fat pad ("buffalo hump"), thin fragile skin with easy bruising and ecchymoses, broad purple striae across the abdomen and thighs, impaired wound healing, osteoporosis (pathological compression fractures), secondary hypertension, steroid-induced hyperglycemia, hypokalemia, metabolic alkalosis, hirsutism, and heightened susceptibility to opportunistic infections.
• Nursing Management: Monitor blood glucose and blood pressure; implement protective skin integrity protocols; handle extremities gently to prevent fractures; monitor daily weights; prepare the patient for surgical resection (transsphenoidal hypophysectomy or adrenalectomy) with planned perioperative glucocorticoid coverage to prevent acute postoperative adrenal crisis.